Immunoprotective response induced by recombinant glycoprotein D in the BALB/c respiratory mouse model of <i>Equid alphaherpesvirus 1</i> infection

Equid alphaherpesvirus 1 (EHV-1) infection causes abortion, respiratory disease, perinatal deaths and neurological disorders in horses. The natural infection and available vaccines provide only partial and short-lived protection against reinfections. In the present study, we analyzed the ability of...

Full description

Bibliographic Details
Authors: Fuentealba, Nadia Analía, Sguazza, Guillermo Hernán, Zanuzzi, Carolina Natalia, Bravi, María Emilia, Scrochi, Mariela Rita, Valera, Alejandro Rafael, Corva, Santiago Gerardo, Gimeno, Eduardo Juan, Pecoraro, Marcelo Ricardo Ítalo, Galosi, Cecilia Mónica
Format: article
Status:Published version
Publication Date:2018
Country:Argentina
Institution:Universidad Nacional de La Plata
Repository:SEDICI (UNLP)
Language:English
OAI Identifier:oai:sedici.unlp.edu.ar:10915/114740
Online Access:http://sedici.unlp.edu.ar/handle/10915/114740
Access Level:Open access
Keyword:Ciencias Veterinarias
Equid alphaherpesvirus 1
Glycoprotein D
Mouse respiratory model
Description
Summary:Equid alphaherpesvirus 1 (EHV-1) infection causes abortion, respiratory disease, perinatal deaths and neurological disorders in horses. The natural infection and available vaccines provide only partial and short-lived protection against reinfections. In the present study, we analyzed the ability of purified baculovirus-expressed glycoprotein D (gD) administered by different routes to induce protective immunity in BALB/c mice after challenge with the EHV-1 AR8 strain. Clinical signs varied among the different groups of mice immunized by parenteral routes, and, although gD induced a specific serum IgG response, it did not prevent the virus from reaching the lungs. Intranasally immunized mice showed no clinical signs, and virus isolation from lungs, histological lesions and antigen detection by immunohistochemistry were negative. In addition, by this route, gD did not stimulate the production of serum IgG and IgA. However, a specific IgA response in the respiratory tract was confirmed in intranasally immunized mice. Thus, we conclude that the mucosal immune response could reduce the initial viral attachment and prevent the virus from reaching the lungs. Our findings provide additional data to further study new immunization strategies in the natural host.